Company Fidson Healthcare Plc

Company Fidson Healthcare Plc

FIDSON

NGFIDSON0006

Pharmaceuticals

Analysts' Consensus

Equities

FIDSON

NGFIDSON0006

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Chiffre d''affaires - Rate of surprise

Sector Generic Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Chiffre d''affaires - Rate of surprise

Sector Generic Pharmaceuticals

End-of-day quote Nigerian S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
14.35 ^NGN	0.00%		-9.75%	-18.00%

Jan. 31	Fidson Healthcare Plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
2023	Fidson Healthcare Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Fidson Healthcare specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of infectious, inflammatory, endocrinal, gastrointestinal, immune, metabolic, cardiovascular, oncological and central nervous system disorders. Net sales break down by activity as follows:

- sale of prescription medicines (70.7%) ;

- sale of OTC products (29.3%).

Number of employees: 650

NGN in Million	2022	Weight	2023	Weight	Delta
Ethical 61.4 %	26,857	66.1 %	32,590	61.4 %	+21.35%
Over-The-Counter 29.9 %	11,924	29.3 %	15,877	29.9 %	+33.16%
Consumer Healthcare (Toll Manufacturing) 8.6 %	1,853	4.6 %	4,583	8.6 %	+147.32%

NGN in Million	2022	Weight	2023	Weight	Delta
Nigeria 100.0 %	40,634	100.0 %	53,050	100.0 %	+30.56%

Managers	Title	Age	Since
Fidelis Ayebae CEO	Chief Executive Officer	-	94-12-31
Imokha Ayebae DFI	Director of Finance/CFO	-	-
Ola Ijimakin BRD	Director/Board Member	-	20-12-31
Olugbenga Olayeye BRD	Director/Board Member	-	94-12-31
Ajayi Olakunle AUD	Comptroller/Controller/Auditor	-	18-07-31
J. Adebanjo SEC	Corporate Secretary	-	-

Members of the board	Title	Age	Since
Olusegun Adebanji CHM	Chairman	-	17-12-31
Fidelis Ayebae CEO	Chief Executive Officer	-	94-12-31
Olufunmilola Ayebae BRD	Director/Board Member	-	00-12-31
Olugbenga Olayeye BRD	Director/Board Member	-	94-12-31
Aisha Sadauki BRD	Director/Board Member	-	11-01-31
Emmanuel Imoagene BRD	Director/Board Member	-	11-01-31
Ekwunife Okoli BRD	Director/Board Member	-	20-12-31
Vincent Ahonkhai BRD	Director/Board Member	-	10-12-31
Ola Ijimakin BRD	Director/Board Member	-	20-12-31
Imokha Ayebae DFI	Director of Finance/CFO	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,086,360,250	1,633,500,000 ( 78.29 %)	0	78.29 %

Name	Equities	%	Valuation
Nomura Asset Management U.K. Ltd. 0.1625 %	3,729,288	0.1625 %	44 304 ₦

Fidson Healthcare Plc

268, Ikorodu Road Obanikoro

100001, Lagos

http://www.fidson.com

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.35 NGN

Average target price

22.47 NGN

Spread / Average Target

+56.59%

Consensus

Company calendar

	1st Jan change	Capi.
FIDSON HEALTHCARE PLC	-18.00%	24.76M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.81%	43.34B
OTSUKA HOLDINGS CO., LTD.	+21.46%	21.96B
SANDOZ GROUP AG	+13.30%	14.09B
CIPLA LIMITED	+12.97%	13.64B
ZYDUS LIFESCIENCES LIMITED	+39.74%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-10.85%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+9.64%	5.22B

Generic Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals